NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following public companies. You can see a copy of the complaints by visiting the links below or you can contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you have suffered damage, you can request that the court appoint you as lead plaintiff. Your ability to participate in a recovery does not require you to serve as lead plaintiff. A lead plaintiff acts on behalf of all other group members in conducting the litigation. The lead plaintiff can select a law firm of his choice. An investor’s ability to participate in a potential future recovery is not contingent on its serving as lead plaintiff.

Humanigen, Inc. HGEN
school lesson: May 28, 2021 – July 12, 2022
Meeting: October 25, 2022
For more information: www.bgandg.com/hgen.
The Complaint alleges that the Defendants made materially false and misleading statements about the Company’s business, operations and prospects throughout the Class Period. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) lenzilumab was less effective in treating hospitalized COVID-19 patients than Defendants had argued; (2) as a result, the FDA was unlikely to approve the lenzilumab EUA and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint; (3) accordingly, the clinical and commercial prospects of lenzilumab have been overstated; and (4) as a result, the Company’s public statements were, at all relevant times, materially false and misleading.

Coupang, Inc. CPNG
school lesson: Class A Coupang common stock pursuant to and/or traceable to the registration statement issued in connection with Coupang’s initial public offering on March 11, 2021 (“IPO”)
Meeting: October 25, 2022
For more information: www.bgandg.com/cpng.
The complaint…